New Two-Tooth clip aims to make stomach tumor removal safer and faster
NCT ID NCT07581977
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new two-tooth clip designed to help doctors remove gastrointestinal stromal tumors (GIST) from the stomach during endoscopy. The clip holds the tumor steady, making it easier to cut away. The trial will compare this method to standard techniques in 60 adults. The goal is to see if the new clip speeds up the procedure and reduces complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A novel two-tooth endoscopic clip (device)
- What this could lead to
- If it works, this could make tumor removal faster and safer, reducing complications during endoscopy.
- What could go wrong
- This is a small, early-stage trial with only 60 people at one center. The clip may not improve outcomes or could cause unexpected issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIST - GASTROINTESTINAL STROMAL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Fifth Medical Center of Chinese PLA General Hospital
RECRUITINGBeijing, 100071, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive GIST registry aims to unlock secrets of rare cancer
- New drug combo shows promise for Hard-to-Treat stomach cancer
- New hope for GIST: experimental combo targets hard-to-treat tumors
- New hope for advanced GIST: experimental drug NB003 takes on resistant tumors
- Scientists launch massive GIST registry to unlock secrets of rare cancer
- Real-World data on ripretinib for advanced GIST: what does it mean for patients?